Expert guidelines advocate defibrillation within 2 minutes after an in-hospital cardiac arrest caused by ventricular arrhythmia. However, empirical data on the prevalence of delayed defibrillation in ...

Early defibrillation plays a key role in improving survival in patients with out-of-hospital cardiac arrests due to ventricular fibrillation (ventricular-fibrillation cardiac arrests), and the use of ...

Researchers used an electrophysiological computer model of the heart's electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios. They ...

If you haven’t had to perform CPR for a patient who was being shocked by an automated implant­able cardioverter defibrillator (AICD), give it time. Approximately 800,000 people in the United States ...

Some patients are having their defibrillation leads taken out early due to shock coil calcification, according to an FDA alert. Boston Scientific has informed healthcare providers that device leads ...

Using light pulses as a model for electrical defibrillation, Göttingen scientists developed a method to assess and modulate the heart function. The research team from the Max Planck Institute for ...

North Shore University Hospital’s cardiology team became the first to complete a procedure using the novel OmniaSecure defibrillation lead on Jan. 7, a landmark in the field of electrophysiology. The ...

St. Anthony Regional Hospital has expanded its advanced cardiac care offerings with the successful implantation of the world’s smallest transvenous defibrillation lead. The procedure was performed by ...

Cardioversion is a procedure that returns an abnormal heart rhythm to normal. It's used when you have an arrhythmia, which means your heart is beating too fast or irregularly. Cardioversion can be ...

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm) lead, which ...